Dag A. Nymoen

Oslo, 0310, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Correction to: Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma.

Correction to: Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma.

Journal: Virchows Archiv : an international journal of pathology

Published: June 01, 2023

Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma.

Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma.

Journal: Virchows Archiv : an international journal of pathology

Published: March 04, 2023

The phosphatase PTPN1/PTP1B is a candidate marker of better chemotherapy response in metastatic high-grade serous carcinoma.

The phosphatase PTPN1/PTP1B is a candidate marker of better chemotherapy response in metastatic high-grade serous carcinoma.

Journal: Cytopathology : official journal of the British Society for Clinical Cytology

Published: September 02, 2020

Expression of palladin is associated with disease progression in metastatic high-grade serous carcinoma.

Expression of palladin is associated with disease progression in metastatic high-grade serous carcinoma.

Journal: Cytopathology : official journal of the British Society for Clinical Cytology

Published: June 23, 2020

MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma.

MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma.

Journal: Human pathology

Published: January 24, 2016

Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma.

Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma.

Journal: Gynecologic oncology

Published: April 23, 2015

CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma.

CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma.

Journal: Molecular cancer

Published: November 14, 2014

APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival.

APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival.

Journal: American journal of clinical pathology

Published: June 14, 2014

A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR.

A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR.

Journal: Leukemia

Published: March 31, 2014

Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia.

Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia.

Journal: PloS one

Published: February 03, 2014

Human papilloma virus detection and typing in 334 lung cancer patients.

Human papilloma virus detection and typing in 334 lung cancer patients.

Journal: Acta oncologica (Stockholm, Sweden)

Published: January 23, 2014

BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma.

BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma.

Journal: Virchows Archiv : an international journal of pathology

Published: December 19, 2013

Showing 1-12 of 18

Last Updated: 09/26/2026